A Study To Evaluate Pregabalin In The Treatment Of Moderate To Severe Chronic Bone Pain Related To Metastatic Cancer

Stopped early · Phase 4 · Has a placebo group

Conditions studied: Bone Neoplasms, Pain, Intractable, Cancer

In brief

The purpose of this study is to assess the analgesic efficacy of flexibly-dosed pregabalin in the adjunctive treatment of subjects with cancer-induced bone pain.

Key facts

Study ID

NCT00381095

Run by

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

People needed

152

Starts

2006-12-01

Expected to finish

2010-10-01

Last updated by the study team

2021-01-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient must have a malignant, solid tumor that has been diagnosed as having metastasized to bone, and must have moderate to severe pain secondary to the bone metastasis at an identifiable reference site.

You may not qualify if…

• The patient who has undergone diagnostic or therapeutic invasive interventions (angiography, biopsy, surgery) less than 15 days prior to study start that would impact their assessment of pain at the reference pain site or area, in the opinion of the investigator.

Where it is running

• Pfizer Investigational Site — Kissimmee, Florida, United States
• Pfizer Investigational Site — Pensacola, Florida, United States
• Pfizer Investigational Site — Pensacola, Florida, United States
• Pfizer Investigational Site — Louisville, Kentucky, United States
• Pfizer Investigational Site — Edina, Minnesota, United States
• Pfizer Investigational Site — Canton, Ohio, United States
• Pfizer Investigational Site — Dover, Ohio, United States
• Pfizer Investigational Site — Hamilton, Ontario, Canada
• Pfizer Investigational Site — Benesov U Prahy, Czechia
• Pfizer Investigational Site — Hořovice, Czechia
• Pfizer Investigational Site — Jablonec nad Nisou, Czechia
• Pfizer Investigational Site — Pilsen, Czechia
• Pfizer Investigational Site — Praha 1 - Nove Mesto, Czechia
• Pfizer Investigational Site — Praha 6 - Hradcany, Czechia
• Pfizer Investigational Site — Cairo, Egypt
• Pfizer Investigational Site — Helsinki, Finland
• Pfizer Investigational Site — Joensuu, Finland
• Pfizer Investigational Site — Bordeaux, France
• Pfizer Investigational Site — Villejuif, France
• Pfizer Investigational Site — Budapest, Hungary
• Pfizer Investigational Site — Budapest, Hungary
• Pfizer Investigational Site — Nyíregyháza, Hungary
• Pfizer Investigational Site — Szentes, Hungary
• Pfizer Investigational Site — Tata, Hungary
• Pfizer Investigational Site — Celebration, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.